Companies: 10,795·Total market cap: $144.5T
Invitae Corporation

Invitae Corporation

NVTAQOTCHealthcare
$0.00
$-0.00(-25.00%)
Market Cap$85948
P/E Ratio
52W High
52W Low
Overview

Invitae Corporation (NVTAQ) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NVTAQ · as of Jun 9, 2026

Key Statistics

EPS (TTM)nvtaq eps ttm · nvtaq earnings per shareEarnings history
PE Ratio (TTM)nvtaq pe ratio ttm · nvtaq price to earningsPE Ratio deep dive
Revenue (TTM)nvtaq revenue ttm · nvtaq annual revenueFull revenue history
Dividend YieldNo Dividenddoes nvtaq pay dividends · nvtaq dividend yieldDividend history
Shares Outstandingnvtaq shares outstanding · nvtaq floatShares outstanding history
Next EarningsTBAnvtaq earnings date · nvtaq next earningsEarnings history

About Invitae Corporation

CEOKenneth D. Knight
IPO DateFeb 12, 2015
Employees1,700
CountryUS

Invitae Corporation (NVTAQ) operates as a medical genetics enterprise, striving to advance healthcare outcomes by furnishing crucial genetic information to individuals across the United States, Canada…

what is invitae corporation · nvtaq stock overview · invitae corporation company profile · who is invitae corporation ceo · nvtaq OTC · invitae corporation headquarters · invitae corporation business segments

About Stock Overview & Key Data

Invitae Corporation (NVTAQ) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Feb 12, 2015. As of the latest trading session, NVTAQ stock price is $0.00, with a market capitalization of $85,948. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Invitae Corporation (NVTAQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol NVTAQ. The 52-week range is $1.00 – $4.00.

NVTAQ stock priceNVTAQ quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice